imaGenes GmbH Joins Roche NimbleGen’s Certified Service Provider Program for ChIP-chip Analysis
News Dec 16, 2009
Roche NimbleGen has announced that imaGenes GmbH, a Berlin-based genomics & proteomics specialist, has achieved status as a Certified Service Provider (CSP) of NimbleGen microarrays for Chromatin Immunoprecipitation (ChIP-chip).
imaGenes GmbH has passed a ChIP-chip certification to officially become part of the Roche NimbleGen Certified Service Provider Program. As a CSP, they will be responsible for processing customer samples for DNA-protein interactions and chromatin structure. They have been certified at their lab in Berlin, Germany using the complete NimbleGen Dual-Color workflow which includes the high-resolution MS 200 Microarray Scanner.
“The precision and flexibility of the NimbleGen Arrays was the decisive factor for imaGenes to immediately apply to Roche NimbleGen’s Certified Service Provider Program and to use the technology in large scale for the “Epifood” project,” says Dr. Steffen Hennig, Director Bioinformatics & Services at imaGenes. “The NimbleGen CSP-status will position imaGenes at the international forefront of microarray application specialists”.
About 422 million people around the world, including more than 30 million Americans, have diabetes. Obesity is the most significant risk factor for type 2 diabetes. yet about 30 percent of obese people do not develop type 2 diabetes or other metabolic conditions. New research aims to understand on a cellular level, how this separation occurs.READ MORE
Measuring hand grip can help identify youths who could benefit from lifestyle changes, says new research. While other studies have shown that muscle weakness as measured by grip strength is a predictor of unhealthy outcomes - including cardiovascular and metabolic diseases - this is the first to do so for adolescent health over time.READ MORE